oxidatic activity, J. Immunol., 124, 1383—1388 (1980).

176. J org A., Henderson W.R., Murphy R.C., Klebanoff S.J. Leukotriene generation by eosinophils, J. Clin. Invest., 155, 390 (1982).

177. Ho P.C, Jjewis R.A., Austen K.F., Orange R.P. Mediators of immediate hypersensitivity. In: Cellular, Molecular and Clinical Aspects of Allergic Disorders, ed. by S. Gupta and R.A. Good, pp. 179—228, Plenum, New York, 1979.

7 . Tanaka K.R., Valentine W.N., Fredericks R.E. Human leukocyte arylsulfatase activity, Br. J. Haematol., 8, 86—92 (1962).

179. Keakou D., Garelly E., Gervais P. The vacuolization of eosinophils and its significance in the skin window test, Acta Allergol., 25, 341—346 (1970).

180. Henderson W.R., Jorg A., Klebanoff S.J. Eosinophil peroxidase-mediated inactivation of leukotrienes B4, C4 and D4, I. Immunol., 128, 2609—2613 (1982).

181. Zucker-Franklin D. Properties of eosinophils. In: Immediate Hypersensitivity, ed. by M.K. Bach, pp. 407—430, Marcel-Dekker, New York, 1978.

182. Weller P.F., Bach D., Austen K.F. Human eosinophil lysoph ispholipase: The sole protein component of charcot-leyden crystals, J. Immunol., 128, 1346—1349 (1982).

183. Weller P.F., Wasserman S.I., Austen K.F. Selected enzymes preferentially present in the eosinophil. In: The Eosinophil in Health and Disease, ed. by A.A.f. Mahmond and K.F. Austen, pp. 115—130, Grune and Stratton, New York, 1980. Ч. В. Паркер

184. Martin T.W., Loganoff D. Interaction of lysophospholipids and mast cells, Nature, 279, 250—252 (1979).

185. Shier W.T. Baldwin О.П., Nilsen-Hamilton M., Hamilton R.T., Thanassi N.M. Regulation of guanylate and adenylate cyclase activities by lysolecithin, Proc. Natl. Acad. Sci. USA, 73, 1586—1590 (1976).

186. Ishizaka K., Tomioka H., Ishizaka T. Mechanisms of passive sensitization. I. Presence of IgE and IgG molecules on human leukocytes, J. Immunol., 105, 1459—1467 (1970).

187. Metcalfe D. D., Kaliner M., Donlon M.A. The mast cell, Crit. Rev. Immunol. 3, 23—74 (1981).

188. Sullivan T.J., Kulczycki A.K., Jr. Immediate hypersensitivity response. In. Clinical Immunology, ed. by C.W. Parker, pp. 115—142, W.B. Saunders, Philadelphia, 1980.

189. Sullivan M.J., Parker С .W. Pharmacologic modulation of inflammatory mediator release by rat mast cells, Am. J. Pathol., 85, 437—463 (1976).

190. Kazmierczak W., Diamant B. Mechanisms of histamine release in anaphyactic and anaphylactoid reactions, Prog. Allergy, 24, 295—365 (1978).

191. Cvorak A. Biology and morphology of basophilic leukocytes. In: Immediate Hypersensitivity, ed. by M.K. Bach, pp. 369—406, Marcel-Dekker, New York, 1978.

192. Plaut M., Lichtenstein L.M. Cellular and chemical basis of the allergic inflammation, response: Component parts and control mechanisms. In: Allergy: Principles and Practice, ed. by E. Middleton, C.E. Reed and E.F. Ellis, pp. 115—138, C.V. Mosby, St. Louis, 1978.

193. Benditt E.P., Lagunoff D. The mast cell: Its structure and function. In: Progress in Allergy, ed. by P. Kallos and B.H. Waksman, pp. 195—223, S. Karger, Basel, 1964.

194. Langunoff D. Cell biology and mast cells and basophils. In: Cell Biology of Inflammation, ed. by G. Weissmann, pp. 217—266, Elsevier/North Holland, New York, 1980.

195. Warwick M.T., Haslam D. Antibodies in some chronic fibrosing lung diseases, Clin. Allergy, 1, 83—95 (1971).

196. Parker C.W. Asthma and rhinitis. In: Clinical Immunol., ed. by C.W. Parker, pp. 1372—1432, W.B. Saunders, Philadelphia, 1980.

197. Solley G.O., Gleich G.J., Jordan R.E., Schroeter A.L. The late phase of the immediate wheal and flare skin reaction: Its independence upon IgE antibodies, J. Clin. Invest., 58, 408 (1976).

198. Dvorak H.F., Hammond M.E. Cutaneous basophil hypersensitivity. In: Immediate Hypersensitivity, ed. by M.K. Bach, pp. 660—692, Maicel-Dekker, New York, 1978.

199. Kniker W.Т., Cochrane C.G. Pathogenic factors in vascular lesions of experimental serum sickness, J. Exp. Med., 122, 83—98 (1965).

200. Camlussi G., Tetta C, Deregibus M.C., Bussolino F., Segoloni G., Vercellone A. Platelet-activating factor (PAF) in experimentally-induced rabbit acute serum sickness: Role of basophil-derived PAF in immune complex deposition, J. Immunol., 128, 86—94 (1982).

201. Askenase P.W., Bursztajn S., Gershon M.D., Gershon R.K. T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity, J. Exp. Med., 152, 1358- 1374 (1980).

202. Ko/ima S., Kitamura Y., Takatsu K. Prolonged infection of nippostrongylus brasiliensis in genetically mast cell-depleted W/Wy mice, Immunol. Lett., 2, 159—162 (1980).

203. Mitchell G.F. Responses to infection with metazoan and protozoan parasites in mice, Adv. Immunol., 28, 451—512 (1978).

204. Day R.P. Basophil leukocyte separation from human peripheral blood. A technique for their isolation in high purity and high yield, Clin. Allergy, 2, 205 (1972).

205. MacGlashan D.W., Lichtenstein L.M. The purification of human basophils, J. Immunol.,

124, 2519-2521 (1980).

206. Befus A.D., Pearce F.L., Gauldie J., Horsewood P., Bienenstock J. Mucosal mast cells. I. Isolation and functional characteristics of rat intestinal mast cells, J. Immunol., 128, 2475-2480 (1982).

207. Pearce F.L., Befus A .D., Gauldie J., Bienenstock J. Mucosal mast cells. II. Effects of antiallergic compounds on histamine secretion by isolated intestinal mast cells, J. Immunology, 128, 2481-2486 (1982).

208. Froese A. The presence of two kinds of receptors for IgE on rat mast cells, J. Immunol.,

125, 981-987 (1980).

209. Metzger II. The cellular receptor for IgE. In: Receptors and Recognition, ed. by P. Cua-„ trecases and M.F. Greaves, pp. 75—102, Chapman and Hall, London, 1977.

^1U. Holowka D., Hartmann H., Kanellopoulos J., Metzger H. Association of the receptor for immunoglobulin E with an endogenous polypeptide on rat basophilic leukemia cells, J. Recept. Res., 1, 41-68 (1980).

211. Hempstead B.L., Parker C.W., Kulczycki A.K., Jr. Characterization of the IgE receptor isolated from human basophils, J. Immunol., 123, 2283—2291 (1979).

27. Медиаторы: высвобождение и функции 212. Conrad D.H., Froese A. Characterization of the target cells receptor for IgE. I. Solubilization of the target cell receptor complexes from rat mast cells and rat basophilic leukemia cells, J. Immunology, 116, 319—326 (1976).

213. Sterk A.R., Ishizaka T. Binding properties of IgE receptors on normal mouse mast cells, J. Immunol., 128, 838—843 (1982).

214. Keller R. Concanavalin A, a model antigen for the in vitro detection of cell bound reage-nic antibody in the rat, Clin. Exp. Immunol., 13, 139—143 (1973).

215. Parker G.W., Kern M., Eisen H.N. Polyfunctional dinitrophenyl haptens as reagents for elicitation of immediate type allergic skin, J. Exp. Med., 115, 789—801 (1962).

216. Parish W.E. Evidence for human IgG antibodies anaphylactically sensitizing man. In: Immediate Hypersensitivity, ed. by M.K. Bach, pp. 277—300, Marcel-Dekker, New York, 1978.

217. Fox P.C, Bascino L.K., Siraganian R.P. Mouse mast cells activation and desensitization for immune aggregate-induced hystamine release, J. Immunol., 129, 314—319 (1982).

218. Vranian G., Conrad D.H., Ruddy S. Specificity of C3 receptors that mediate phagocytosis by rat peritoneal mast cells, J. Immunol., 126, 2302—2306 (1981).

219. Hugli Т.Е. The structural basis for anaphylactoxin and chemotactic functions of СЗа, C4a and C5a, Crit. Rev. Immunol., 1, 321—366 (1981).

220. Findlay S.R., Dvorak A.M., Kagey-Sobotka A., Lichtenstein L.M. Hyperosmolar triggering of hystamine release from human basophils, J. Clin. Invest., 67, 1604—1613 (1981).

221. Stanworth D.R., Kings M., Roy P.D., Moran J M., Мог an D.M. Synthetic peptides comprising sequences of the human immunoglobulin E heavy chain capable of releasing histamine, Biochem. J., 180, 665—668 (1979).

222. Findlay S.R., LU .tensiein L.M., Grant J .A. Generation of slow reacting substance by human leukocytes. II. Comparison of stimulation by antigen, anti-IgE, calcium ionophore and C5-peptide, J. Immunol., 124, 238—242 (1980).

223. Hook W.A., Schiffman E.A., Swanikumar S., Suriginian R.P. Histamine release by chemotactic, formyl methionine-containing peptides, J. Immunol., 117, 594—596 (1976).

224. Barrizai A.K., Kretscmer R.R. Enhancement of antigen-induced leukocyte histamine release by a mononuclear cell-derived factor, J. Allergy Clin. Immunol., 62, 137—142 (1978).

225. Thueson D.O., Speck L., Grant J.A. Histamine releasing activity produced by human mononuclear cells, Fed. Proc, 36, 1300a (1976).

226. Theoharidec T.C., Betchaku Т., Douglas W.W. Somatostatin-induced histamine secretion in n>ast cells. Characterization of the effect, Eur. J. Pharmacol., 69, 127—137 (1981).

227. Yecies L.D., Johnston S.M., Wedner H.J., Parker C.W. Slow reacting substance (SRS) from ionophore A23187 stimulated peritoneal mast cells of the normal rat. II. Evidence for a precursor role of arachidonic acid and further purification, J. Immunol., 122, 2090— 2095 (1979).

228. Stenson W.F., Parker C.W., Sull ivan T.J., Augmentation of IgE-mediated release of histamine by hydroxyeicosatetraenoic acid and 12-hydroxyeicosatetraenoic acid, Biochem. Biophys. Res. Commun., 96, 1045—1052 (1980).

229. Sullivan W.F., Parker C.W. Poss ble role of arachidonic acid and its metabolites in mediator release from rat mast cells, J. Immunol., 122, 431—436 (1979).

230. Peters S.P., Siege M.I., Kegey-Sobotka A., Lichtenstein L.M. Lipoxygenase products modulate histamine release in human basophils, Nature, 292, 455—457 (1981).

231. Lett-Brown M.A., Aelvoet M., Hooks J.J., Georgiades J.A., Thueson D.O., Grant J.A. Enhancement of basophil chemotaxis in vitro by virus-induced interferon, J. Clin. Invest., 67, 547-552 (1981).

232. Yodoi J., Hir